Australia  

Gilead's remdesivir gets U.S. FDA approval

Video Credit: Reuters Studio - Duration: 01:29s - Published
Gilead's remdesivir gets U.S. FDA approval

Gilead's remdesivir gets U.S. FDA approval

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States.

Gavino Garay reports.


You Might Like


💡 One News Page Knowledge: Other News Mentions

Gilead Sciences American pharmaceutical company

Word Health Organisation Advises Against Remdesivir for COVID-19 Treatment [Video]

Word Health Organisation Advises Against Remdesivir for COVID-19 Treatment

A World Health Organisation (WHO) panel announced on Friday that Gilead’s remdesivir should not be used on COVID-19 patients

Credit: Cover Video STUDIO    Duration: 01:19Published

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

COVID-19 Vaccine May Cause Flu-Like Symptoms [Video]

COVID-19 Vaccine May Cause Flu-Like Symptoms

Americans need to be prepared for the possibility that they may feel a little unwell. After you get a coronavirus vaccine, if one is authorized, you may experience some negative side effects. The CDC met to discuss whether to recommend the use of any Covid-19 vaccines. The US Food and Drug Administration or FDA is the agency that might authorize one. Volunteers in vaccine trials have reported they frequently feel flu-like effects after getting vaccinated.

Credit: Wochit News    Duration: 00:39Published
Dow Jumps 210 Points On Vaccine News From AstraZeneca [Video]

Dow Jumps 210 Points On Vaccine News From AstraZeneca

On Monday, US stocks rose. AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%. This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness. S&P 500: 3,580.82, up 0.7% Dow Jones industrial average: 29,473.41, up 0.7% (210 points) Nasdaq composite: 11,929.04, up 0.6%

Credit: Wochit News    Duration: 00:37Published
Pfizer submits Emergency Use Authorization request to FDA for its COVID-19 vaccine [Video]

Pfizer submits Emergency Use Authorization request to FDA for its COVID-19 vaccine

Pfizer announced Friday that it would submit a request to the FDA Friday for its COVID-19 vaccine to be granted Emergency Use Authorization.

Credit: ABC Action News    Duration: 01:51Published
How Long Will It Take To Vaccinate All Americans? [Video]

How Long Will It Take To Vaccinate All Americans?

There are currently two COVID-19 vaccines promising results from their Phase 3 trials. Moderna announced that its vaccine was 94.5% effective. Pfizer/BioNTech announced that their vaccine was 95% effective. How long will it take for all Americans to be vaccinated? If the FDA approves the vaccine, Business Insider says first responders and vulnerable populations will receive vaccines through March.

Credit: Wochit News    Duration: 00:34Published
The WHO No Longer Recommends Remdesivir For COVID-19 Patients [Video]

The WHO No Longer Recommends Remdesivir For COVID-19 Patients

The FDA approved remdesivir as a treatment for severe COVID-19 cases last month. This is after granting emergency authorization in May, reports Business Insider. But on Thursday, the WHO announced it will not recommend the drug's use for COVID-19 patients. "There is currently no evidence that it improves survival or the need for ventilation," the organization said. Remdesivir was the first coronavirus treatment to receive emergency authorization from the FDA.

Credit: Wochit News    Duration: 00:39Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

COVID-19: Lock manufactures in Aligarh yet to overcome difficulties [Video]

COVID-19: Lock manufactures in Aligarh yet to overcome difficulties

Lock hardware business in Aligarh suffered setback due to lockdown. In the month of July, situation between India and Nepal further deepened their woes. While industries are gradually coming on track, Extant COVID crisis continues to diminish hopes. "Due to restrictions in some states it's difficult for our agents and they can't collect demands. Sellers think they won't be able to sell, so they're neither buying raw material nor supplying to us," said C Sharma, Tala Nagri Industrialist Association's Chairman.

Credit: ANI    Duration: 01:58Published
Birx worried about COVID spike after holiday [Video]

Birx worried about COVID spike after holiday

[NFA] The White House coronavirus task force coordinator Dr. Deborah Birx on CBS’s ‘Face The Nation’ Sunday said she is increasingly concerned about a potential new spike in COVID-19 infections after Thanksgiving, as lawmakers continue to stall on legislation that could be crucial to vaccine distribution. Gavino Garay has more.

Credit: Reuters Studio    Duration: 02:08Published
Struggling father faces pressures ahead of Christmas during Covid-19 [Video]

Struggling father faces pressures ahead of Christmas during Covid-19

Mike Trower, 32, a single parent from Paignton in Devon, was forced to put onhold plans to open a new business as the Covid-19 crisis unfolded.

Credit: PA - Press Association STUDIO    Duration: 01:35Published

Related videos from verified sources

Daily Covid-19 Minute: Remdesivir Approved By FDA As First Covid-19 Drug [Video]

Daily Covid-19 Minute: Remdesivir Approved By FDA As First Covid-19 Drug

Breaking news in the coronavirus pandemic. The FDA has just approved Gilead’s drug - Remdesivir - as a treatment for Covid-19.

Credit: CBS 62 Detroit     Duration: 01:16Published